12497656

Source:http://linkedlifedata.com/resource/pubmed/id/12497656

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0008976, umls-concept:C0302592, umls-concept:C0425358, umls-concept:C0725066, umls-concept:C1273870, umls-concept:C1521808, umls-concept:C2700615
pubmed:issue	6
pubmed:dateCreated	2002-12-23
pubmed:abstractText	Despite effective screening methods for detecting pre- malignant diseases of the cervix, cervical cancer remains a leading cause of cancer mortality in women globally. There has been a dramatic decline in the age adjusted death rate from cervical cancer in the United States, where cervical cancer has declined from the leading cause of cancer mortality in women prior to 1940 to a point where it is a relatively uncommon cause of cancer mortality today. Despite these advances in screening and early detection reported in the United States, intraepithelial disease detection rates in many non-industrialized countries remain low because screening programs are generally lacking. As a result most cancers detected in many underdeveloped areas of the world are advanced at diagnosis. Furthermore, in such countries there may be inadequacies in physicians trained in the most effective means of treating cervical cancer, technical support required for the effective delivery of radiation therapy or the administration of chemotherapy, and modern equipment required for optimal treatment with radiation therapy. Thus cure rates for women with cervical cancers in many areas of the world remain low.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0414003
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0513-5796
pubmed:author	pubmed-author:BermanMichael LML
pubmed:issnType	Print
pubmed:volume	43
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	729-36
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12497656-Clinical Trials as Topic, pubmed-meshheading:12497656-Combined Modality Therapy, pubmed-meshheading:12497656-Female, pubmed-meshheading:12497656-Humans, pubmed-meshheading:12497656-Uterine Cervical Neoplasms
pubmed:year	2002
pubmed:articleTitle	Advances in cervical cancer management from North American cooperative group clinical trials.
pubmed:affiliation	Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, UCI Medical Center, 101 The City Drive, Bldg. 23, Orange, California 92868-3298, USA. mberman@msx.ndc.mc.uci.edu
pubmed:publicationType	Journal Article, Review